{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:10:02Z","timestamp":1778170202208,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["7212016"],"award-info":[{"award-number":["7212016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While the 2019 novel coronavirus disease (COVID-19) pandemic has resulted in millions of cases worldwide, there is increasing recognition of a wide range of ocular manifestations associated with the virus, including uveitis. Uveitis is an inflammatory condition of the uveal tract of the eye that can lead to permanent vision loss if not treated promptly. Here we report a retrospective observational study of patients who presented with new onset or recurrent uveitis following COVID-19 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective observational study conducted at the Beijing Tongren Hospital. We identified patients who presented with symptoms of non-infectious active uveitis with positive real-time reverse transcription polymerase chain reaction (RT-PCR) of COVID-19 within 4 weeks. All patients received ophthalmic examinations, including anterior and posterior segment imaging, to assess the extent of ocular involvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 18 patients with a total of 33 eyes included in this study presented with symptoms of active uveitis within 4 weeks of their positive COVID-19 RT-PCR test. Among them, 9 patients presented with the development of uveitis following COVID-19 infection, and 9 patients had relapsed uveitis after COVID-19 infection. Treatment with corticosteroids resulted in improvement of symptoms and resolution of inflammation in all cases. In this study, all patients did not experience any adverse drug reactions during treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our observational study highlights the potential for new onset or recurrence of uveitis following COVID-19 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/\">https:\/\/www.chictr.org.cn\/<\/jats:ext-link>; identifier: ChiCTR2100044365, date: 03\/17\/2023.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03289-w","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:02:27Z","timestamp":1705482147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["New onset or recurrence of uveitis following COVID-19 infection"],"prefix":"10.1186","volume":"24","author":[{"given":"Hui","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xusheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"issue":"10223","key":"3289_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470\u20133.","journal-title":"Lancet"},{"issue":"7","key":"3289_CR2","doi-asserted-by":"publisher","first-page":"102573","DOI":"10.1016\/j.autrev.2020.102573","volume":"19","author":"S Colafrancesco","year":"2020","unstructured":"Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020;19(7):102573.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3289_CR3","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1097\/IJG.0000000000001835","volume":"30","author":"RS Alonso","year":"2021","unstructured":"Alonso RS, Alonso FOM, Fernandes BF, Ecard VO, Ventura MP. COVID-19\u2013related ocular hypertension secondary to Anterior Uveitis as Part of a multisystemic inflammatory syndrome. J Glaucoma. 2021;30(5):e256\u2013e8.","journal-title":"J Glaucoma"},{"key":"3289_CR4","doi-asserted-by":"crossref","unstructured":"Ganesh S, Mohanan-Earatt A. An analysis of the clinical profile of patients with uveitis following COVID-19 infection. Indian J Ophthalmol. 2022;70(3).","DOI":"10.4103\/ijo.IJO_2735_21"},{"key":"3289_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/IMCRJ.S312461","volume":"14","author":"S Iriqat","year":"2021","unstructured":"Iriqat S, Yousef Q, Ereqat S. Clinical Profile of COVID-19 patients presenting with Uveitis - A Short Case Series. Int Med Case Rep J. 2021;14:421\u20137.","journal-title":"Int Med Case Rep J"},{"issue":"6","key":"3289_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/09273948.2020.1792512","volume":"28","author":"B Benito-Pascual","year":"2020","unstructured":"Benito-Pascual B, Gegundez JA, Diaz-Valle D, Arriola-Villalobos P, Carreno E, Culebras E, et al. Panuveitis and Optic Neuritis as a possible initial presentation of the Novel Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922\u20135.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"3289_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.survophthal.2021.08.006","volume":"67","author":"G De Salvo","year":"2022","unstructured":"De Salvo G, Meduri A, Vaz-Pereira S, Spencer D. An uncommon cold of the retina. Surv Ophthalmol. 2022;67(5):1553\u20138.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"3289_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.autrev.2017.10.018","volume":"17","author":"P Grumet","year":"2018","unstructured":"Grumet P, Kodjikian L, de Parisot A, Errera MH, Sedira N, Heron E, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev. 2018;17(4):331\u201343.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3289_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmv.27292","volume":"94","author":"N Yazdanpanah","year":"2021","unstructured":"Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol. 2021;94(1):54\u201362.","journal-title":"J Med Virol"},{"key":"3289_CR10","doi-asserted-by":"crossref","unstructured":"Przybek-Skrzypecka J, Szewczuk A, Kaminska A, Skrzypecki J, Pyziak-Skupien A, Szaflik JP. Effect of COVID-19 lockdowns on Eye Emergency Department, increasing prevalence of Uveitis and Optic Neuritis in the COVID-19 era. Healthc (Basel). 2022;10(8).","DOI":"10.3390\/healthcare10081422"},{"issue":"6","key":"3289_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/ICU.0000000000000801","volume":"32","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Stewart JM. Retinal and choroidal manifestations of COVID-19. Curr Opin Ophthalmol. 2021;32(6):536\u201340.","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"3289_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00347-021-01486-2","volume":"118","author":"A Heiligenhaus","year":"2021","unstructured":"Heiligenhaus A, Rothaus K, Pleyer U. [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group]. Ophthalmologe. 2021;118(9):913\u20138.","journal-title":"Ophthalmologe"},{"issue":"3","key":"3289_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","volume":"28","author":"I Seah","year":"2020","unstructured":"Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391\u20135.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"3289_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.5642","volume":"254","author":"LE van Eijk","year":"2021","unstructured":"van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021;254(4):307\u201331.","journal-title":"J Pathol"},{"issue":"1","key":"3289_CR15","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, et al. Evasion of type I Interferon by SARS-CoV-2. Cell Rep. 2020;33(1):108234.","journal-title":"Cell Rep"},{"issue":"1","key":"3289_CR16","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11(1):3810.","journal-title":"Nat Commun"},{"issue":"1","key":"3289_CR17","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1038\/s41467-020-19706-9","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, et al. Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020;11(1):5859.","journal-title":"Nat Commun"},{"issue":"5","key":"3289_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, Moller R, et al. Imbalanced host response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020;181(5):1036\u201345e9.","journal-title":"Cell"},{"key":"3289_CR19","doi-asserted-by":"crossref","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential Interaction and Molecular mechanisms. Viruses. 2019;11(8).","DOI":"10.3390\/v11080762"},{"issue":"11","key":"3289_CR20","doi-asserted-by":"publisher","first-page":"e0241661","DOI":"10.1371\/journal.pone.0241661","volume":"15","author":"K Aggarwal","year":"2020","unstructured":"Aggarwal K, Agarwal A, Jaiswal N, Dahiya N, Ahuja A, Mahajan S, et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0241661.","journal-title":"PLoS ONE"},{"key":"3289_CR21","doi-asserted-by":"crossref","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the Novel Coronavirus from Wuhan: an analysis based on Decade-Long Structural studies of SARS Coronavirus. J Virol. 2020;94(7).","DOI":"10.1128\/JVI.00127-20"},{"key":"3289_CR22","doi-asserted-by":"crossref","unstructured":"Vienne-Jumeau A, Br\u00e9zin AP, Debieb A. Bilateral anterior uveitis following paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2\u2013 case report and focused review. Ocul Immunol Inflamm. 2022:1\u20135.","DOI":"10.1080\/09273948.2022.2143381"},{"issue":"4","key":"3289_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jmv.27521","volume":"94","author":"AYC Sim","year":"2021","unstructured":"Sim AYC, Naffi AA, Fai TS, Kori N, Zaidi WAW, Periyasamy P, et al. Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection. J Med Virol. 2021;94(4):1269\u201371.","journal-title":"J Med Virol"},{"issue":"8","key":"3289_CR24","first-page":"810","volume":"18","author":"S Grabbe","year":"2020","unstructured":"Grabbe S, Beissert S, Enk A. Systemic immunosuppression in times of COVID-19: do we need to rethink our standards? J Dtsch Dermatol Ges. 2020;18(8):810\u20133.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7813","key":"3289_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/d41586-020-01824-5","volume":"582","author":"H Ledford","year":"2020","unstructured":"Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020;582(7813):469.","journal-title":"Nature"},{"issue":"7","key":"3289_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ophtha.2020.03.026","volume":"127","author":"IYJ Seah","year":"2020","unstructured":"Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Assessing viral shedding and infectivity of tears in Coronavirus Disease 2019 (COVID-19) patients. Ophthalmology. 2020;127(7):977\u20139.","journal-title":"Ophthalmology"},{"issue":"5","key":"3289_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0039-6257(93)90064-E","volume":"37","author":"SL Yoser","year":"1993","unstructured":"Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol. 1993;37(5):313\u201352.","journal-title":"Surv Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03289-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T09:05:14Z","timestamp":1705482314000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3289"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03289-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board and ethics committee of Beijing Tongren Hospital and was conducted in accordance with the principles of the Helsinki Declaration. All patients provided written informed consent to use their data for analysis and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish this information was obtained from study participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}